Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Change in Accured Expenses (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Change in Accured Expenses readings, the most recent being -$3.3 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 58.01% to -$3.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Mar 2026, down 710.06% year-over-year, with the annual reading at -$7.2 million for FY2025, 497.04% down from the prior year.
  • Change in Accured Expenses hit -$3.3 million in Q1 2026 for Oric Pharmaceuticals, down from -$448000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $3.9 million in Q3 2023 and bottomed at -$7.9 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is -$408235.3, with a median of -$158000.0 recorded in 2022.
  • The largest annual shift saw Change in Accured Expenses skyrocketed 682.2% in 2023 before it plummeted 627.02% in 2024.
  • Oric Pharmaceuticals' Change in Accured Expenses stood at $1.4 million in 2022, then crashed by 32.2% to $979000.0 in 2023, then soared by 209.09% to $3.0 million in 2024, then plummeted by 114.81% to -$448000.0 in 2025, then plummeted by 641.52% to -$3.3 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Change in Accured Expenses are -$3.3 million (Q1 2026), -$448000.0 (Q4 2025), and $1.4 million (Q3 2025).